J. Goldman & Co’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,936
Closed -$254K 682
2025
Q3
$254K Buy
2,936
+236
+9% +$18.7K 0.01% 410
2025
Q2
$206K Buy
+2,700
New +$198K ﹤0.01% 416
2025
Q1
Sell
-23,100
Closed -$1.81M 580
2024
Q4
$1.81M Buy
23,100
+20,400
+756% +$1.91M 0.05% 281
2024
Q3
$276K Sell
2,700
-3,756
-58% -$312K 0.01% 396
2024
Q2
$490K Sell
6,456
-13,708
-68% -$975K 0.01% 361
2024
Q1
$1.51M Buy
+20,164
New +$1.6M 0.05% 239

Other funds holding NUVL

J. Goldman & Co's NUVL Position: Q4 2025 in Review

J. Goldman & Co sold out of Nuvalent (NUVL) in Q4 2025, closing a stake of 2,936 shares — an estimated $254K sold.

J. Goldman & Co first reported a position in NUVL in Q1 2024 and held it in 6 quarters. The position peaked at $1.81M in Q4 2024. 237 funds tracked by Wall St. Rank hold NUVL as of Q4 2025.

  • J. Goldman & Co reported no remaining Nuvalent position as of Q4 2025 after selling out during the quarter.
  • J. Goldman & Co sold 2,936 Nuvalent shares in Q4 2025, an estimated $254K.
  • J. Goldman & Co first reported a position in Nuvalent in Q1 2024 and held it in 6 quarters.
  • J. Goldman & Co's Nuvalent position peaked at $1.81M in Q4 2024.
  • 237 funds tracked by Wall St. Rank held Nuvalent as of Q4 2025.

Based on J. Goldman & Co's 13F filing for Q4 2025, filed 17 Feb 2026.